Nicolet Advisory Services LLC Increases Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Nicolet Advisory Services LLC lifted its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 5.6% in the 3rd quarter, Holdings Channel.com reports. The firm owned 3,366 shares of the biotechnology company’s stock after purchasing an additional 177 shares during the period. Nicolet Advisory Services LLC’s holdings in Axon Enterprise were worth $1,397,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. PFG Investments LLC raised its holdings in Axon Enterprise by 0.6% during the third quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company’s stock worth $1,547,000 after purchasing an additional 25 shares in the last quarter. Gladstone Institutional Advisory LLC raised its stake in Axon Enterprise by 1.6% during the 3rd quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company’s stock worth $656,000 after acquiring an additional 26 shares in the last quarter. Mather Group LLC. raised its stake in Axon Enterprise by 3.7% during the 3rd quarter. Mather Group LLC. now owns 759 shares of the biotechnology company’s stock worth $303,000 after acquiring an additional 27 shares in the last quarter. King Luther Capital Management Corp lifted its position in Axon Enterprise by 0.3% in the third quarter. King Luther Capital Management Corp now owns 10,474 shares of the biotechnology company’s stock valued at $4,185,000 after acquiring an additional 34 shares during the last quarter. Finally, CWM LLC boosted its stake in Axon Enterprise by 1.3% in the third quarter. CWM LLC now owns 2,856 shares of the biotechnology company’s stock valued at $1,141,000 after acquiring an additional 36 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, Director Jeri Williams sold 110 shares of the stock in a transaction on Monday, September 30th. The stock was sold at an average price of $400.00, for a total value of $44,000.00. Following the completion of the transaction, the director now owns 1,934 shares in the company, valued at approximately $773,600. This represents a 5.38 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, President Joshua Isner sold 20,000 shares of the company’s stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the transaction, the president now directly owns 208,166 shares in the company, valued at approximately $126,179,820.90. This trade represents a 8.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 330,256 shares of company stock worth $131,338,820 over the last 90 days. Company insiders own 6.10% of the company’s stock.

Axon Enterprise Stock Up 0.9 %

AXON stock opened at $636.95 on Friday. Axon Enterprise, Inc. has a one year low of $224.28 and a one year high of $641.20. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The company has a fifty day moving average of $458.43 and a 200-day moving average of $365.54. The stock has a market capitalization of $48.57 billion, a PE ratio of 164.59, a price-to-earnings-growth ratio of 18.89 and a beta of 0.94.

Wall Street Analyst Weigh In

AXON has been the topic of a number of research analyst reports. Robert W. Baird lifted their target price on Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Northland Securities lifted their price target on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. Needham & Company LLC increased their price objective on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. Barclays lifted their target price on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a report on Wednesday, August 7th. Finally, JMP Securities increased their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research note on Thursday, October 31st. Two research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $427.83.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.